Lv53
880 积分 2022-10-28 加入
Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study
4小时前
求助中
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study
1天前
已完结
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults
7天前
已完结
Immunosuppressant and neuromyelitis optica spectrum disorder: optimal treatment duration and risk of discontinuation
1个月前
已完结
Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre study
1个月前
已完结
Comparison on the effect of seven drugs to prevent relapses of neuromyelitis optica spectrum disorders: A modeling analysis of literature aggregate data
2个月前
已完结
Association of B cell Subsets and Aquaporin-4 antibody titers with Disease Activity in Participants in the N-MOmentum trial Receiving Inebilizumab Treatment (S5.005)
4个月前
已关闭
Immunobiology of neuromyelitis optica spectrum disorders
4个月前
已完结
Efficacy of monoclonal antibodies in neuromyelitis optica: An updated systematic review with meta‐analysis
4个月前
已完结
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
4个月前
已完结
皖公网安备34019202002308
